Zepbound bests Wegovy for weight loss in new trial
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Healthcare News
Early weight loss with tirzepatide predictive of larger cardiometabolic benefits later on
Tirzepatide confers significant weight loss and cardiometabolic benefits for patients with diabetes and overweight or obesity, especially for those who lose more weight earlier during treatment
Fasting, eating earlier in the day or eating fewer meals—what works best for weight loss?
Modifying your diet is important for managing obesity and preventing weight gain. This might include reducing your calorie intake, changing your eating patterns and prioritizing healthy food. But is one formula for weight loss more likely to result in success than another? Our new research compared three weight-loss methods, to see if one delivered more weight loss than the others.
Meta-analysis links meal timing to modest weight loss
Researchers at Bond University in Robina, Australia, have found that meal timing strategies such as time-restricted eating, reducing meal frequency, and consuming calories earlier in the day are associated with modest weight loss over 12 weeks.
Benefits of weight loss from bariatric surgery extend to blood pressure control
Bariatric surgery for weight loss was associated with improvements in blood pressure and antihypertensive use among patients with obesity compared with medical therapy and/or lifestyle management
